Global PD 1PD L1 Immunotherapy Market Research Report 2023(Status and Outlook)
- Published Date: 2023-08-20
- Report ID: 146775
- Pages: 250
-
Format:
Report Overview
A protein found on T cells (a type of immune cell) that helps keep the body's immune responses in check. WhenPD-1is bound to another protein calledPD-L1, it helps keep T cells from killing other cells, including cancer cells. Some anticancer drugs, called immune checkpoint inhibitors, are used to blockPD-1.
Prudent Markets latest report provides a deep insight into the global PD 1PD L1 Immunotherapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porters five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global PD 1PD L1 Immunotherapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the PD 1PD L1 Immunotherapy market in any manner.
Global PD 1PD L1 Immunotherapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca Plc
BeiGene, Ltd.
Bristol-Myers Squibb Company
Chia Tai Tianqing Pharmaceutical Group Co. Ltd.
Eli Lilly & Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline plc
Innovent Biologics, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Regeneron Pharmaceuticals Inc.
Sanofi S.A.
Market Segmentation (by Type)
PD-1 Inhibitors
PD-L1 Inhibitors
Market Segmentation (by Application)
Non-Small Cell Lung Cancer
Esophageal Cancer
Urothelial Carcinoma
Hepatocellular Carcinoma
Small Cell Lung Cancer
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the PD 1PD L1 Immunotherapy Market
Overview of the regional outlook of the PD 1PD L1 Immunotherapy Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porters five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the PD 1PD L1 Immunotherapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of PD 1PD L1 Immunotherapy
1.2 Key Market Segments
1.2.1 PD 1PD L1 Immunotherapy Segment by Type
1.2.2 PD 1PD L1 Immunotherapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PD 1PD L1 Immunotherapy Market Overview
2.1 Global Market Overview
2.1.1 Global PD 1PD L1 Immunotherapy Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global PD 1PD L1 Immunotherapy Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PD 1PD L1 Immunotherapy Market Competitive Landscape
3.1 Global PD 1PD L1 Immunotherapy Sales by Manufacturers (2018-2023)
3.2 Global PD 1PD L1 Immunotherapy Revenue Market Share by Manufacturers (2018-2023)
3.3 PD 1PD L1 Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global PD 1PD L1 Immunotherapy Average Price by Manufacturers (2018-2023)
3.5 Manufacturers PD 1PD L1 Immunotherapy Sales Sites, Area Served, Product Type
3.6 PD 1PD L1 Immunotherapy Market Competitive Situation and Trends
3.6.1 PD 1PD L1 Immunotherapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest PD 1PD L1 Immunotherapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PD 1PD L1 Immunotherapy Industry Chain Analysis
4.1 PD 1PD L1 Immunotherapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of PD 1PD L1 Immunotherapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PD 1PD L1 Immunotherapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global PD 1PD L1 Immunotherapy Sales Market Share by Type (2018-2023)
6.3 Global PD 1PD L1 Immunotherapy Market Size Market Share by Type (2018-2023)
6.4 Global PD 1PD L1 Immunotherapy Price by Type (2018-2023)
7 PD 1PD L1 Immunotherapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global PD 1PD L1 Immunotherapy Market Sales by Application (2018-2023)
7.3 Global PD 1PD L1 Immunotherapy Market Size (M USD) by Application (2018-2023)
7.4 Global PD 1PD L1 Immunotherapy Sales Growth Rate by Application (2018-2023)
8 PD 1PD L1 Immunotherapy Market Segmentation by Region
8.1 Global PD 1PD L1 Immunotherapy Sales by Region
8.1.1 Global PD 1PD L1 Immunotherapy Sales by Region
8.1.2 Global PD 1PD L1 Immunotherapy Sales Market Share by Region
8.2 North America
8.2.1 North America PD 1PD L1 Immunotherapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe PD 1PD L1 Immunotherapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific PD 1PD L1 Immunotherapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America PD 1PD L1 Immunotherapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa PD 1PD L1 Immunotherapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AstraZeneca Plc
9.1.1 AstraZeneca Plc PD 1PD L1 Immunotherapy Basic Information
9.1.2 AstraZeneca Plc PD 1PD L1 Immunotherapy Product Overview
9.1.3 AstraZeneca Plc PD 1PD L1 Immunotherapy Product Market Performance
9.1.4 AstraZeneca Plc Business Overview
9.1.5 AstraZeneca Plc PD 1PD L1 Immunotherapy SWOT Analysis
9.1.6 AstraZeneca Plc Recent Developments
9.2 BeiGene, Ltd.
9.2.1 BeiGene, Ltd. PD 1PD L1 Immunotherapy Basic Information
9.2.2 BeiGene, Ltd. PD 1PD L1 Immunotherapy Product Overview
9.2.3 BeiGene, Ltd. PD 1PD L1 Immunotherapy Product Market Performance
9.2.4 BeiGene, Ltd. Business Overview
9.2.5 BeiGene, Ltd. PD 1PD L1 Immunotherapy SWOT Analysis
9.2.6 BeiGene, Ltd. Recent Developments
9.3 Bristol-Myers Squibb Company
9.3.1 Bristol-Myers Squibb Company PD 1PD L1 Immunotherapy Basic Information
9.3.2 Bristol-Myers Squibb Company PD 1PD L1 Immunotherapy Product Overview
9.3.3 Bristol-Myers Squibb Company PD 1PD L1 Immunotherapy Product Market Performance
9.3.4 Bristol-Myers Squibb Company Business Overview
9.3.5 Bristol-Myers Squibb Company PD 1PD L1 Immunotherapy SWOT Analysis
9.3.6 Bristol-Myers Squibb Company Recent Developments
9.4 Chia Tai Tianqing Pharmaceutical Group Co. Ltd.
9.4.1 Chia Tai Tianqing Pharmaceutical Group Co. Ltd. PD 1PD L1 Immunotherapy Basic Information
9.4.2 Chia Tai Tianqing Pharmaceutical Group Co. Ltd. PD 1PD L1 Immunotherapy Product Overview
9.4.3 Chia Tai Tianqing Pharmaceutical Group Co. Ltd. PD 1PD L1 Immunotherapy Product Market Performance
9.4.4 Chia Tai Tianqing Pharmaceutical Group Co. Ltd. Business Overview
9.4.5 Chia Tai Tianqing Pharmaceutical Group Co. Ltd. PD 1PD L1 Immunotherapy SWOT Analysis
9.4.6 Chia Tai Tianqing Pharmaceutical Group Co. Ltd. Recent Developments
9.5 Eli Lilly and Company
9.5.1 Eli Lilly and Company PD 1PD L1 Immunotherapy Basic Information
9.5.2 Eli Lilly and Company PD 1PD L1 Immunotherapy Product Overview
9.5.3 Eli Lilly and Company PD 1PD L1 Immunotherapy Product Market Performance
9.5.4 Eli Lilly and Company Business Overview
9.5.5 Eli Lilly and Company PD 1PD L1 Immunotherapy SWOT Analysis
9.5.6 Eli Lilly and Company Recent Developments
9.6 F. Hoffmann-La Roche Ltd
9.6.1 F. Hoffmann-La Roche Ltd PD 1PD L1 Immunotherapy Basic Information
9.6.2 F. Hoffmann-La Roche Ltd PD 1PD L1 Immunotherapy Product Overview
9.6.3 F. Hoffmann-La Roche Ltd PD 1PD L1 Immunotherapy Product Market Performance
9.6.4 F. Hoffmann-La Roche Ltd Business Overview
9.6.5 F. Hoffmann-La Roche Ltd Recent Developments
9.7 GlaxoSmithKline plc
9.7.1 GlaxoSmithKline plc PD 1PD L1 Immunotherapy Basic Information
9.7.2 GlaxoSmithKline plc PD 1PD L1 Immunotherapy Product Overview
9.7.3 GlaxoSmithKline plc PD 1PD L1 Immunotherapy Product Market Performance
9.7.4 GlaxoSmithKline plc Business Overview
9.7.5 GlaxoSmithKline plc Recent Developments
9.8 Innovent Biologics, Inc.
9.8.1 Innovent Biologics, Inc. PD 1PD L1 Immunotherapy Basic Information
9.8.2 Innovent Biologics, Inc. PD 1PD L1 Immunotherapy Product Overview
9.8.3 Innovent Biologics, Inc. PD 1PD L1 Immunotherapy Product Market Performance
9.8.4 Innovent Biologics, Inc. Business Overview
9.8.5 Innovent Biologics, Inc. Recent Developments
9.9 Jiangsu HengRui Medicine Co., Ltd.
9.9.1 Jiangsu HengRui Medicine Co., Ltd. PD 1PD L1 Immunotherapy Basic Information
9.9.2 Jiangsu HengRui Medicine Co., Ltd. PD 1PD L1 Immunotherapy Product Overview
9.9.3 Jiangsu HengRui Medicine Co., Ltd. PD 1PD L1 Immunotherapy Product Market Performance
9.9.4 Jiangsu HengRui Medicine Co., Ltd. Business Overview
9.9.5 Jiangsu HengRui Medicine Co., Ltd. Recent Developments
9.10 Merck and Co., Inc.
9.10.1 Merck and Co., Inc. PD 1PD L1 Immunotherapy Basic Information
9.10.2 Merck and Co., Inc. PD 1PD L1 Immunotherapy Product Overview
9.10.3 Merck and Co., Inc. PD 1PD L1 Immunotherapy Product Market Performance
9.10.4 Merck and Co., Inc. Business Overview
9.10.5 Merck and Co., Inc. Recent Developments
9.11 Novartis AG
9.11.1 Novartis AG PD 1PD L1 Immunotherapy Basic Information
9.11.2 Novartis AG PD 1PD L1 Immunotherapy Product Overview
9.11.3 Novartis AG PD 1PD L1 Immunotherapy Product Market Performance
9.11.4 Novartis AG Business Overview
9.11.5 Novartis AG Recent Developments
9.12 Pfizer Inc.
9.12.1 Pfizer Inc. PD 1PD L1 Immunotherapy Basic Information
9.12.2 Pfizer Inc. PD 1PD L1 Immunotherapy Product Overview
9.12.3 Pfizer Inc. PD 1PD L1 Immunotherapy Product Market Performance
9.12.4 Pfizer Inc. Business Overview
9.12.5 Pfizer Inc. Recent Developments
9.13 Regeneron Pharmaceuticals Inc.
9.13.1 Regeneron Pharmaceuticals Inc. PD 1PD L1 Immunotherapy Basic Information
9.13.2 Regeneron Pharmaceuticals Inc. PD 1PD L1 Immunotherapy Product Overview
9.13.3 Regeneron Pharmaceuticals Inc. PD 1PD L1 Immunotherapy Product Market Performance
9.13.4 Regeneron Pharmaceuticals Inc. Business Overview
9.13.5 Regeneron Pharmaceuticals Inc. Recent Developments
9.14 Sanofi S.A.
9.14.1 Sanofi S.A. PD 1PD L1 Immunotherapy Basic Information
9.14.2 Sanofi S.A. PD 1PD L1 Immunotherapy Product Overview
9.14.3 Sanofi S.A. PD 1PD L1 Immunotherapy Product Market Performance
9.14.4 Sanofi S.A. Business Overview
9.14.5 Sanofi S.A. Recent Developments
10 PD 1PD L1 Immunotherapy Market Forecast by Region
10.1 Global PD 1PD L1 Immunotherapy Market Size Forecast
10.2 Global PD 1PD L1 Immunotherapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe PD 1PD L1 Immunotherapy Market Size Forecast by Country
10.2.3 Asia Pacific PD 1PD L1 Immunotherapy Market Size Forecast by Region
10.2.4 South America PD 1PD L1 Immunotherapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of PD 1PD L1 Immunotherapy by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global PD 1PD L1 Immunotherapy Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of PD 1PD L1 Immunotherapy by Type (2024-2029)
11.1.2 Global PD 1PD L1 Immunotherapy Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of PD 1PD L1 Immunotherapy by Type (2024-2029)
11.2 Global PD 1PD L1 Immunotherapy Market Forecast by Application (2024-2029)
11.2.1 Global PD 1PD L1 Immunotherapy Sales (K MT) Forecast by Application
11.2.2 Global PD 1PD L1 Immunotherapy Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
